Bo von Schoultz

No ORCID on file · 11 papers in corpus · active 1982-2009

Study types

  • article 11

Condition tags

  • endometriosis 3
  • die_deep_infiltrating 1
article 2009
Reproductive biomedicine online ·doi:10.1016/s1472-6483(10)60138-1

This study reports on anti-Müllerian hormone (AMH) in serum and follicular fluid (FF) in relation to inflammatory parameters in women with and without endometriosis undergoing IVF. Serum and FF samples were obtained from 72 women, with (n =…

article 2004
Fertility and Sterility ·doi:10.1016/j.fertnstert.2004.02.096

ObjectiveTo study the effect on mammographic breast density of two different continuous combined regimens for hormone therapy.DesignRandomized clinical study.SettingUniversity hospital.Patient(s)Postmenopausal women without any previous his…

article 2003
·doi:10.1023/a:1022987618445

The basis of breast cancer risk associated with hormonal therapies may lie in the regulation of cell proliferation. In a prospective, double-blind, randomized study postmenopausal women were given continuous combined hormone replacement the…

article 2003

A combination of 2 mg estradiol valerate with 2 mg dienogest (E2V/DNG) (Climodien, Schering AG, Berlin, Gemany) is the first continuous combined postmenopausal hormone replacement therapy (HRT) preparation to contain a progestogen with subs…

article 1999
·doi:10.3109/13625189909085260

Oral contraceptives have over 70 million users world-wide and are regarded as one of the most reliable forms of contraception, but unfortunately their full potential is not yet completely realized. Many women associate long-term oral contra…

article 1993
·doi:10.3109/01674829309084451

Conflicting data have been reported on the psychosexual impact of hysterectomy combined with bilateral oophorectomy. Three age-matched, hysterectomized groups of women were investigated: Group A (n = 33): oophorectomized, not receiving estr…

article 1989
·doi:10.1016/0378-5122(89)90120-5

Silicone vaginal rings for the continuous release of 17 beta-oestradiol (E2) with 2 constant in vitro release rates were used for the treatment of symptoms of urogenital atrophy in 2 groups of postmenopausal women. The very low dose of 7 mi…

article 1985
·doi:10.1016/s0015-0282(16)48612-7

The interaction of medroxyprogesterone acetate (MPA) with cortisol binding to corticosteroid-binding globulin (CBG) was studied with the use of an aqueous two-phase system with polyethylene glycol and dextran for equilibrium partition. Comp…

article 1983
Fertility and Sterility ·doi:10.1016/s0015-0282(16)46941-4

Danazol is a testosterone (T) derivative widely used in the clinical treatment of endometriosis. Its mechanism of action is poorly understood, but is side effects are mainly androgenic. Previously it was demonstrated that danazol can displa…

article 1982
·doi:10.1016/0022-4731(82)90391-0
article 1982
Fertility and Sterility ·doi:10.1016/s0015-0282(16)46395-8

The mechanism of action of danazol is poorly understood, but this testosterone (T) derivate is frequently used in the clinical treatment of endometriosis, and its tendency to androgenic/anabolic side effects is well known. The interaction o…